Dendrite Clinical Systems’ unique and innovation clinical software is been employed for a new innovative Quality Improvement, Patient Safety and Research trial that is seeking to improve the quality of care delivered to patients requiring hip or knee joint replacement surgery by introducing two complimentary care-bundles for mild anaemia and Methicillin Sensitive Staphylococcus aureus (MSSA) into routine clinical practice.
Dendrite Clinical Systems is to install its “Intellect System” to track outcomes of cardiothoracic surgery at the Cardiothoracic and Vascular Intensive Care and High Dependency Unit, Auckland City Hospital, Auckland, New Zealand. The establishment of a Dendrite system at the unit will improve the quality of data and coding quality by creating effective clinical data entry and reporting, and data validation. 
Dendrite Clinical Systems and the Society for Cardiothoracic Surgery in the UK are pleased to announce the SCTS Conference News 201 newspaper is now available to view/download. This is the third successive year Dendrite has published the newspaper on behalf of the SCTS. The newspaper reports a multitude of presentations from the meeting including the latest and the best information on new technologies and techniques in cardio-thoracic surgery. 
Dendrite Clinical Systems, the publisher of Bariatric News, is pleased to announce issue 35 of the newspaper is now available to view/download. The newspaper reports on research, technology, events and policy in the bariatric specialty, the latest clinical studies, policy changes and product news, the latest meetings and events, interviews prominent bariatric experts, and host debates between specialists on controversial topics.
The United Kingdom National Bariatric Surgery Registry 3rd Report (2020)
-
Code:ISBN 978-1-9160207-2-6
Published by Dendrite Clinical Systems, in conjunction with the British Obesity and Metabolic Surgery Society (BOMSS), the third iteration of the National Bariatric Surgery Registry Report builds on the previous two and includes data on an additional 38,388 patients taking the overall total to 70,461 patients. The report demonstrates the safety and effectiveness of bariatric and metabolic surgery in the UK. The report uses data from the National Bariatric Surgery Registry (NBSR), a decade long research collaboration between BOMSS and Dendrite Clinical Systems. Key highlights of the publication include:
- Bariatric Surgery procedures produced excess weight loss at one year of 73.7% after One Anastomosis Gastric Bypasses and 71.3% after Roux-en-Y gastric bypass, which compares favourably against 61.5% with sleeve gastrectomy and 38.8% with gastric banding.
- The effectiveness of surgery also reveals that the prevalence of Type 2 diabetes mellitus was reduced from 30% to 14% in the first year after surgery.
- In-hospital mortality from bariatric and metabolic surgery was very low at 0.04%, which compares very favourably with internationally accepted figures.
